Gene · 4173
Papers2,283
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,283
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Topoisomerase I Inhibition in ETV4-overexpressed Non-Small Cell Lung Cancer Promotes Replication and Transcription Mediated R-Loop Accumulation and DNA Damage. | Adv Sci (Weinh) | 2025 | 40548893 | PubTator, text mining | PubMed |
| Transcription factor E2F1 promotes non-small cell lung cancer progression by activating the PI3K/AKT pathway through MCM4. | J Cardiothorac Surg | 2025 | 40437556 | PubTator, text mining | PubMed |
| [Molecular genetics in pediatric endocrinology: 35 years of research]. | Probl Endokrinol (Mosk) | 2025 | 40411325 | PubTator, text mining | PubMed |
| Gene expression-based identification of prognostic markers in lung adenocarcinoma. | PLoS One | 2025 | 40333815 | PubTator, text mining | PubMed |
| Proteomic analysis reveals potential biomarker candidates in serous ovarian tumors - a preliminary study. | Contemp Oncol (Pozn) | 2025 | 40330446 | PubTator, text mining | PubMed |
| Comprehensive analysis of lactylation-related gene and immune microenvironment in atrial fibrillation. | Front Cardiovasc Med | 2025 | 40329965 | PubTator, text mining | PubMed |
| The identification and prediction of lung adenocarcinoma prognosis using a novel gene signature associated with DNA replication. | Transl Cancer Res | 2025 | 40224989 | PubTator, text mining | PubMed |
| Biomarkers and potential function analysis of triple-negative breast cancer screening based on bioinformatics. | Cancer Biomark | 2025 | 40179432 | PubTator, text mining | PubMed |
| E2F7 upregulates MCM4 and fatty acid metabolism to advance lung adenocarcinoma metastasis. | Prostaglandins Other Lipid Mediat | 2025 | 40158794 | PubTator, text mining | PubMed |
| Transcriptomic Profiling Highlights Metabolic and Biosynthetic Pathways Involved in In Vitro Flowering in Anoectochilus roxburghii (Wall.) Lindl. | Genes (Basel) | 2025 | 40004461 | PubTator, text mining | PubMed |
| Refinement and curation of homologous groups facilitated by structure prediction. | Protein Sci | 2025 | 39968854 | PubTator, text mining | PubMed |
| Primary adrenal insufficiency in children excluding congenital adrenal hyperplasia: insights from 33-year single-center experience in Tunisia. | Arch Pediatr | 2025 | 39875217 | PubTator, text mining | PubMed |
| TanGIBLE: A selective probe for evaluating hydrophobicity-exposed defective proteins in live cells. | J Cell Biol | 2025 | 39812643 | PubTator, text mining | PubMed |
| Functional Analysis and Experimental Validation of the Prognostic and Immune Effects of the Oncogenic Protein CDC45 in Breast Cancer. | Breast Cancer (Dove Med Press) | 2025 | 39811603 | PubTator, text mining | PubMed |
| MCM2-7 ring closure involves the Mcm5 C-terminus and triggers Mcm4 ATP hydrolysis. | Nat Commun | 2025 | 39747125 | PubTator, text mining | PubMed |
| Unraveling the genetic basis of azoospermia: transcriptome profiling analyses in a Greek population. | F S Sci | 2025 | 39515755 | PubTator, text mining | PubMed |
| MCM4 Promotes the Progression of Malignant Melanoma by Activating the PI3K/AKT Pathway. | Environ Toxicol | 2025 | 39501995 | PubTator, text mining | PubMed |
| Recurrent hepatocellular carcinoma is associated with the enrichment of MYC targets gene sets, elevated high confidence deleterious mutations and alternative splicing of DDB2 and BRCA1 transcripts. | Adv Med Sci | 2025 | 39486583 | PubTator, text mining | PubMed |
| Network-base approaches to identify therapeutic biomarkers in hepatocellular carcinoma and search for drug hunting utilizing molecular dynamics simulations. | J Biomol Struct Dyn | 2025 | 38486461 | PubTator, text mining | PubMed |
Integrated analysis of cell cycle and p53 signaling pathways related genes in breast, colorectal, lung, and pancreatic cancers: implications for prognosis and drug sensitivity for therapeutic potential. | Discov Oncol | 2024 | 39715832 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4173/papers?page=3